A20表达降低与眼白塞病(BD)相关而与Vogt-Koyanagi-Harada(VKH)病无关
本研究检测了活动性与非活动性葡萄膜炎期白塞病(BD)患者、Vogt-Koyanagi-Harada(VKH)病患者及正常对照的外周血单个核细胞(PBMC)和树突状细胞(DC)中A20表达,发现A20在活动性葡萄膜炎BD患者中显著降低,而在VKH病患者中与正常对照相比无显著差异。体外沉默DC中A20可增加IL-1β、IL-6和CD4+ T细胞IL-17产生,抑制IL-10和IL-27,并增加磷酸化JNK和p38表达,但不影响DC表面标志物。作者认为A20表达降低可能通过增强促炎Th17细胞活化导致BD复发。
要点
- 活动性葡萄膜炎BD患者PBMC和DC中A20表达较正常对照显著降低,VKH病患者无此变化。
- 沉默DC中A20可增加IL-1β、IL-6及CD4+ T细胞IL-17产生,抑制IL-10和IL-27。
- 沉默A20增加磷酸化JNK和p38表达,但不影响DC表面CD40、CD80、CD83、CD86和HLA-DR。
核心结论
- 本研究表明A20在活动性葡萄膜炎BD患者中表达降低,而在VKH病中无降低。
- A20表达降低可能通过增强促炎Th17细胞活化导致BD复发。
研究设计与样本
- 检测活动性与非活动性葡萄膜炎BD患者、活动性与非活动性葡萄膜炎VKH病患者及正常对照的PBMC和DC中A20水平,方法为实时PCR。
- 通过转导含A20 shRNA载体的腺病毒沉默DC中A20,用流式细胞术检测DC成熟,用ELISA分析DC和CD4+ T细胞细胞因子产生,用流式细胞术检测JNK、p38和ERK1/2磷酸化水平。
主要发现
- 活动性葡萄膜炎BD患者PBMC和DC中A20表达较正常对照显著降低,VKH病患者与正常对照相比无显著降低。
- 沉默A20显著增加IL-1β和IL-6水平,抑制抗炎细胞因子IL-10和IL-27表达。
- A20下调导致CD4+ T细胞IL-17产生增加。
- DC中A20下调对细胞表面标志物CD40、CD80、CD83、CD86和HLA-DR无影响。
- 沉默A20导致磷酸化JNK和磷酸化MAPK p38表达增加,但磷酸化ERK1/2无增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A20 is a ubiquitously expressed and inducible cytosolic protein, which plays an important role in the negative regulation of inflammation and immunity. In this study, we investigated the role of A20 in Behcet's disease (BD) and Vogt-Koyanagi-Harada (VKH) disease. METHODS: The levels of A20 in peripheral blood mononuclear cells (PBMCs) and dendritic cells (DCs) were detected in BD patients with active and inactive uveitis, VKH patients with active and inactive uveitis, and normal subjects, respectively, by real-time PCR. The effect of A20 silencing was performed by transduction of DCs with adenovirus containing an A20 shRNA vector. The effect of A20 silencing on the maturation of DCs was measured by flow cytometry. The effect of A20 silencing of DCs on cytokine production by DCs and CD4+ T cells was analysed by ELISA. The phosphorylation levels of JNK, p38 and ERK1/2 were detected by flow cytometry. RESULTS: The expression of A20 was markedly decreased in PBMCs and DCs obtained from BD patients with active uveitis, but not in patients with VKH disease as compared with normal controls. Silencing of A20 significantly increased the levels of interleukin (IL)-1β and IL-6 and suppressed the expression of the anti-inflammatory cytokines IL-10 and IL-27. Downregulation of A20 also led to an increase in IL-17 production by CD4+ T cells. However, downregulation of A20 in DCs did not have an effect on cell surface markers such as CD40, CD80, CD83, CD86 and HLA-DR. Silencing of A20 caused an increased expression of phospho-JNK and phospho-MAPK p38 but not phospho-ERK1/2. CONCLUSIONS: This study showed that the expression of A20 was decreased in BD patients with active uveitis but not in VKH disease. Decreased expression of A20 may lead to an enhanced activation of proinflammatory Th17 cells, causing a reactivation of BD.
引用
- He Y, Wang C, Su G, et al. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease. Br J Ophthalmol. 2018. PMID: 29699987. doi:10.1136/bjophthalmol-2017-311707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。